Stay updated on MK-2870-004 Clinical Trial
Sign up to get notified when there's something new on the MK-2870-004 Clinical Trial page.

Latest updates to the MK-2870-004 Clinical Trial page
- Check5 days agoChange DetectedThe page revision updated from v3.6.2 to v3.6.3, indicating a new version of the study record. This likely reflects minor edits or corrections to the page.SummaryDifference0.0%

- Check12 days agoChange DetectedRevision: v3.6.2 is now shown on the page, indicating an updated version of the page. This reflects a minor revision to the page rather than a substantive content change.SummaryDifference0.0%

- Check19 days agoChange DetectedAdds a detailed study purpose describing the comparison between sacituzumab tirumotecan and chemotherapy for NSCLC with EGFR mutations or other genomic alterations, and introduces explicit primary and secondary endpoints (OS and PFS) with definitions and time frames; older language about multiple primary hypotheses has been removed.SummaryDifference0.3%

- Check26 days agoChange DetectedNew help and navigation sections were added to assist visitors in understanding the study record, including How to Read a Study Record, Common Questions, and How to Join a Study, plus a note that enrollment is 'No longer looking for participants'. The Intervention/Treatment header formatting was standardized, and the page revision badge shows v3.6.0.SummaryDifference0.1%

- Check33 days agoChange DetectedA new page revision, v3.5.5, was added and the previous revision v3.5.4 was removed. This reflects a deployment/format update to the page rather than a change to the study details.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page shows a new revision (v3.5.4) with updated dates, signaling refreshed study details. The deletions remove trial contact information and recruitment status indicators, affecting who can contact the study and how enrollment is presented.SummaryDifference8%

Stay in the know with updates to MK-2870-004 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-2870-004 Clinical Trial page.